NCT05589922

Brief Summary

This study will aim to compare ankylosing spondylitis (AS) participants with abnormal modified Schober index (AMSI) versus AS participants with normal modified Schober index (NMSI) in pain, morning stiffness, balance, kinesiophobia and the fear of falling. In addition, the investigators will aim to determine which demographic characteristics and variables predispose AMSI to occur

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 21, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

October 24, 2022

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 18, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2023

Completed
Last Updated

June 12, 2023

Status Verified

June 1, 2023

Enrollment Period

25 days

First QC Date

October 18, 2022

Last Update Submit

June 9, 2023

Conditions

Keywords

Ankylosing SpondylitisSpinal mobilityKinesiophobiaBalance

Outcome Measures

Primary Outcomes (6)

  • Modified Schober Index

    The measurement of the MSI starts with the subject in an upright posture. After being determined the posterior superior iliac spines, a horizontal line is drawn at the center of both posterior superior iliac spines. Ten cm above and five cm below the first line are marked. The distance between the top and bottom line is remeasured after the patient attempts to flex forward as far as possible while keeping the knees straight

    at baseline

  • Bath AS Metrology Index (BASMI)

    The BASMI is evulated quantify the mobility of the axial skeleton and includes assessments of lateral lumbar flexion, tragus-to-wall distance, lumbar flexion, intermalleolar distance, and cervical rotation. Each measure is assigned a score of 0 to 2 with the higher score indicating greater impairment in mobility

    at baseline

  • Timed up and go test

    It aims to assess mobility and balance. It measures the time in seconds for a subject to stand up from an armchair, walk 3 m, turn, walk back to the chair, and sit down

    at baseline

  • tandem stance test

    For the tandem stance test, patients stand holding onto a railing while placing one foot in front of the other. The researcher standing behind the patient starts timing when the patient's contact with the railing is released. It is recorded for 30 seconds or until participants contact external support or move out of tandem stance

    At baseline

  • Falls Efficacy Scale-International

    The FES-I consists of 16 questions questioning how confident patients are in performing activities without falling. According to the answers, each question is scored between 1 and 4 (1 = not at all concerned, 4 = very concerned), and a higher score is associated with a greater fear of falling

    At baseline

  • Tampa Scale for Kinesiophobia

    The TSK contains 17 questions which measures fear of movement and/or reinjury. The scale uses 4-point Likert scoring (1 = entirely disagree, 4 = entirely agree). A total score ranges from 11 to 44 points and a cut-off point was determined as ≥37 points indicate a high kinesiophobia level

    At baseline

Secondary Outcomes (5)

  • functional reach test

    At baseline

  • 30-second chair sit-to-stand test

    At baseline

  • single leg stance test

    At baseline

  • finger-to-floor distance measure

    At baseline

  • Visual Analogue Scale

    At baseline

Study Arms (2)

Patients with abnormal modified Schober index

This group will include the patients with Ankylosing Spondylitis who have modified Schober index smaller than 5 cm

Patients with normal modified Schober index

This group will include the patients with Ankylosing Spondylitis who have modified Schober index bigger than 5 cm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Ankylosing Spondylitis

You may qualify if:

  • Participants who meet the modified New York criteria for AS
  • Participants over 18 years

You may not qualify if:

  • Participants with other concomitant rheumatic diseases (such as fibromyalgia, rheumatoid arthritis, etc.),
  • Participants with cognitive or psychiatric disorders,
  • Participants with neuromuscular or orthopedic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hatay Mustafa Kemal University, Faculty of Health Science, Department of Physiotherapy and Rehabilitation

Hatay, Alahan, 31060, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Spondylitis, AnkylosingKinesiophobia

Condition Hierarchy (Ancestors)

Axial SpondyloarthritisSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritisPhobic DisordersAnxiety DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

October 18, 2022

First Posted

October 21, 2022

Study Start

October 24, 2022

Primary Completion

November 18, 2022

Study Completion

January 30, 2023

Last Updated

June 12, 2023

Record last verified: 2023-06

Locations